Hannah Renae Lord, Physician Assistant Medicare: Medicare Enrolled Practice Location: 800 Garfield Ave, Parkersburg, WV 26101 Phone: 304-424-2355 |
Terrance Huntar Shank, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 800 Garfield Ave, Parkersburg, WV 26101 Phone: 304-588-9684 |
Victoria Foutty, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 800 Garfield Ave, Parkersburg, WV 26101 Phone: 304-424-2355 |
News Archive
A protein that helps lung cancer cells thrive appears to do so by blocking healthy cells' ability to fix themselves when radiation or chemicals such as nicotine damage their DNA, according to a University of Florida study to be published Friday (Feb. 29) in the journal Molecular Cell.
3M Health Care today announced the launch of 3M™ Tegaderm™ I.V. Advanced Securement Dressing for patients, a comprehensive solution with transparent, breathable film, a stabilization border and new, comfort adhesive technology. The new dressing is perceived by clinicians to reduce catheter manipulation and resist staining which could lead to less frequent dressing changes, and may provide a cost savings option for hospitals.
A team at the University of Oxford has received a grant of £160,000 from Arthritis Research UK to study the function of the genes which contribute to people developing a painful inflammatory back condition called ankylosing spondylitis.
How well a person with type 2 diabetes responds to a diabetes drug may well depend upon his or her genetic make-up, according to a study published in the May issue of Diabetes Care. The study found that people who carried certain genotypes responded less favorably to rosiglitazone, a drug often prescribed for people with diabetes, than carriers of other genotypes.
AssureRx Health, Inc. today announced the closing of a $12.5 million Series C financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug for individual neuropsychiatric patients, will use the funds to increase commercial activities for its two flagship pharmacogenomic products, GeneSightRx Psychotropic and GeneSightRx® ADHD, as well as next generation product development activities.
› Verified 4 days ago